202 related articles for article (PubMed ID: 18686088)
1. Development of a tamsulosin hydrochloride controlled-release capsule consisting of two different coated pellets.
Zhang X; Tang X; Yang R
Drug Dev Ind Pharm; 2009 Jan; 35(1):26-33. PubMed ID: 18686088
[TBL] [Abstract][Full Text] [Related]
2. Evaluating tamsulosin hydrochloride-released microparticles prepared using single-step matrix coating.
Maeda A; Shinoda T; Ito N; Baba K; Oku N; Mizumoto T
Int J Pharm; 2011 Apr; 408(1-2):84-90. PubMed ID: 21291970
[TBL] [Abstract][Full Text] [Related]
3. Sustained-release pellets prepared by combination of wax matrices and double-layer coatings for extremely water-soluble drugs.
Tian L; Zhang Y; Tang X
Drug Dev Ind Pharm; 2008 Jun; 34(6):569-76. PubMed ID: 18568906
[TBL] [Abstract][Full Text] [Related]
4. Preparation and stability investigation of tamsulosin hydrochloride sustained release pellets containing acrylic resin polymers with two different techniques.
Fan R; Sun Y; Li B; Yang R; Ma W; Sun J
Asian J Pharm Sci; 2017 Mar; 12(2):193-201. PubMed ID: 32104330
[TBL] [Abstract][Full Text] [Related]
5. Preparation and in vitro/in vivo evaluation of sustained-release venlafaxine hydrochloride pellets.
Liu Y; Sun Y; Sun J; Zhao N; Sun M; He Z
Int J Pharm; 2012 Apr; 426(1-2):21-28. PubMed ID: 22266529
[TBL] [Abstract][Full Text] [Related]
6. The influence of Surelease and sodium alginate on the in-vitro release of tamsulosin hydrochloride in pellet dosage form.
Kim MS; Jun SW; Lee S; Lee TW; Park JS; Hwang SJ
J Pharm Pharmacol; 2005 Jun; 57(6):735-42. PubMed ID: 15969928
[TBL] [Abstract][Full Text] [Related]
7. Development of Novel Tamsulosin Pellet-Loaded Oral Disintegrating Tablet Bioequivalent to Commercial Capsule in Beagle Dogs Using Microcrystalline Cellulose and Mannitol.
Cho HJ; Kim JS; Jin SG; Choi HG
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895073
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of the stability of venlafaxine hydrochloride sustained-release pellets prepared by double-polymer coatings and hot-melt subcoating combined with Eudragit(®) NE30D outercoating.
Guan T; Wang J; Li G; Tang X
Pharm Dev Technol; 2011 Jun; 16(3):269-77. PubMed ID: 20214529
[TBL] [Abstract][Full Text] [Related]
9. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system.
Serratoni M; Newton M; Booth S; Clarke A
Eur J Pharm Biopharm; 2007 Jan; 65(1):94-8. PubMed ID: 17056237
[TBL] [Abstract][Full Text] [Related]
10. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
11. Preparation and evaluation of nicotinic acid sustained-release pellets combined with immediate release simvastatin.
Zhao X; Li G; Zhang L; Tao X; Guan T; Hong M; Tang X
Int J Pharm; 2010 Nov; 400(1-2):42-8. PubMed ID: 20801201
[TBL] [Abstract][Full Text] [Related]
12. A method for the preparation of sustained release-coated Metoprolol Succinate pellet-containing tablets.
Yang Z; Yu J; Yang T; Xing H; Zhang J; Xian L; Ding P; Wang D
Pharm Dev Technol; 2016 Dec; 21(8):943-950. PubMed ID: 26334840
[TBL] [Abstract][Full Text] [Related]
13. Preparation and bioavailability of sustained-release doxofylline pellets in beagle dogs.
Huang HF; Lu Y; He HB; Tang X
Drug Dev Ind Pharm; 2008 Jul; 34(7):676-82. PubMed ID: 18608467
[TBL] [Abstract][Full Text] [Related]
14. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
Hu LD; Liu Y; Tang X; Zhang Q
Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948
[TBL] [Abstract][Full Text] [Related]
15. Dual coating of swellable and rupturable polymers on glipizide loaded MCC pellets for pulsatile delivery: formulation design and in vitro evaluation.
Yadav D; Survase S; Kumar N
Int J Pharm; 2011 Oct; 419(1-2):121-30. PubMed ID: 21807081
[TBL] [Abstract][Full Text] [Related]
16. Statistical optimization of tamsulosin hydrochloride controlled release pellets coated with the blend of HPMCP and HPMC.
Kim JS; Kim MS; Park HJ; Lee S; Park JS; Hwang SJ
Chem Pharm Bull (Tokyo); 2007 Jun; 55(6):936-9. PubMed ID: 17541199
[TBL] [Abstract][Full Text] [Related]
17. Preparation and in vitro evaluation of pH, time-based and enzyme-degradable pellets for colonic drug delivery.
Fude C; Lei Y; Jie J; Hongze P; Wenhui L; Dongmei C
Drug Dev Ind Pharm; 2007 Sep; 33(9):999-1007. PubMed ID: 17891587
[TBL] [Abstract][Full Text] [Related]
18. Development and optimization of a novel oral controlled delivery system for tamsulosin hydrochloride using response surface methodology.
Kim MS; Kim JS; You YH; Park HJ; Lee S; Park JS; Woo JS; Hwang SJ
Int J Pharm; 2007 Aug; 341(1-2):97-104. PubMed ID: 17499949
[TBL] [Abstract][Full Text] [Related]
19. Preparation and in vitro/in vivo evaluation of esomeprazole magnesium-modified release pellets.
Kan SL; Lu J; Liu JP; Zhao Y
Drug Deliv; 2016; 23(3):866-73. PubMed ID: 24892629
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo evaluation of levofloxacin sustained-release capsules.
Yin LF; Huang SJ; Jiang SG; Zhao CJ; Pei ZQ; Zhang Q
Drug Dev Ind Pharm; 2011 Jan; 37(1):33-40. PubMed ID: 20545503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
